Retatrutide (10 mg)

Retatrutide is a next-generation triple receptor agonist that has become one of the most talked-about peptides in metabolic research. Acting on GLP-1, GIP, and glucagon receptors simultaneously, Retatrutide represents a significant advancement in multi-target peptide science.

Key research areas include:

• Triple GLP-1, GIP, and glucagon receptor agonism

•  Weight management and metabolic pathway modulation

• Appetite regulation and energy expenditure research

• Glycaemic control and insulin response studies

• One of the most actively studied peptides in current clinical trials

 
Supplied at 10 mg potency with 99%+ purity, backed by third-party HPLC analysis and full Certificate of Analysis.

For laboratory and research use only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.